Cision PR Newswire

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution Conference Call Scheduled: August 21 at...

FMS 2026 | Longsys Chief Scientist Jian Chen Highlights the Storage Foundry Model for Edge AI

SAN JOSE, Calif., Aug. 7, 2026 /PRNewswire/ -- At FMS 2026 on August 5, Longsys (301308.SZ) Chief Scientist Dr. Jian Chen delivered a keynote speech...

NutriPQQ® Publishes New PQQ Sourcing Guide for Supplement Brands and Manufacturers

The new B2B resource helps procurement, formulation, and quality teams evaluate PQQ production methods, ingredient identity, testing, stability, packaging, and supply continuity. Key...

Alebund’s AP301 NDA Accepted for Review by China’s NMPA

SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the...

ASTRI Achieves Strongest Representation in Asia at 2026 R&D 100 Awards, with Three Technologies Named Global Winners

HONG KONG, Aug. 7, 2026 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has achieved a landmark milestone at the...